Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Chromatogr ; 29(11): 1629-36, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26010453

ABSTRACT

Inositol is a six-carbon sugar alcohol and is one of nine biologically significant isomers of hexahydroxycyclohexane. Myo-inositol is the primary biologically active form and is present in higher concentrations in the fetus and newborn than in adults. It is currently being examined for the prevention of retinopathy of prematurity in newborn preterm infants. A robust method for quantifying myo-inositol (MI), D-chiro-inositol (DCI) and 1,5-anhydro- D-sorbitol (ADS) in very small-volume (25 µL) urine, blood serum and/or plasma samples was developed. Using a multiple-column, multiple mobile phase liquid chromatographic system with electrochemical detection, the method was validated with respect to (a) selectivity, (b) accuracy/recovery, (c) precision/reproducibility, (d) sensitivity, (e) stability and (f) ruggedness. The standard curve was linear and ranged from 0.5 to 30 mg/L for each of the three analytes. Above-mentioned performance measures were within acceptable limits described in the Food and Drug Administration's Guidance for Industry: Bioanalytical Method Validation. The method was validated using blood serum and plasma collected using four common anticoagulants, and also by quantifying the accuracy and sensitivity of MI measured in simulated urine samples recovered from preterm infant diaper systems. The method performs satisfactorily measuring the three most common inositol isomers on 25 µL clinical samples of serum, plasma, milk, and/or urine. Similar performance is seen testing larger volume samples of infant formulas and infant formula ingredients. MI, ADS and DCI may be accurately tested in urine samples collected from five different preterm infant diapers if the urine volume is greater than 2-5 mL.


Subject(s)
Chromatography, High Pressure Liquid/methods , Electrochemical Techniques/methods , Inositol/analysis , Isosorbide/analysis , Adult , Humans , Inositol/blood , Inositol/urine , Isomerism , Isosorbide/blood , Isosorbide/urine , Reference Standards
2.
Arzneimittelforschung ; 34(9): 1031-5, 1984.
Article in English | MEDLINE | ID: mdl-6542370

ABSTRACT

Single oral doses of 20 mg of the carbon-14 labelled form of the antianginal drug isosorbide 5-mononitrate (5-ISMN, Elantan) were essentially completely absorbed and excreted fairly rapidly in the urine. Means of 24, 52, 78, 93 and 96% dose were excreted during 6, 12, 24, 48 and 120 h, respectively. Concentrations of 14C reached peak levels at about 1-2 h when about 86% of the 14C was associated with the parent drug, 5-ISMN (peak mean level 430 ng/ml), and the remainder mainly with the pharmacologically-inactive denitrated product isosorbide. Because the plasma (and urinary) half-life of isosorbide was longer (about 8-9 h) than that of 5-ISMN (about 4.5 h), the proportions of the former in plasma increased relative to the latter. Concentrations of 14C in whole-blood and plasma were similar, implying that 5-ISMN diffused into blood cells. Concentrations of 5-ISMN in saliva and plasma were almost identical, presumably because of the almost negligible plasma protein binding of the drug (less than 5%). At least five metabolites of 5-ISMN were detected in urine - these were isosorbide (about 37% dose), conjugated material (about 25% dose) presumably mainly 5-ISMN-glucuronide, sorbitol (about 7% dose), the parent drug 5-ISMN (about 2% dose) and two unidentified metabolites (about 7 and 4% dose, respectively). The conjugated material was excreted in the urine relatively more rapidly than the denitrated product, isosorbide.


Subject(s)
Isosorbide Dinitrate/analogs & derivatives , Adult , Biotransformation , Chromatography, Thin Layer , Humans , Isosorbide/blood , Isosorbide/metabolism , Isosorbide/urine , Isosorbide Dinitrate/blood , Isosorbide Dinitrate/metabolism , Isosorbide Dinitrate/urine , Male , Mass Spectrometry , Saliva/metabolism , Time Factors
3.
J Chromatogr ; 277: 157-64, 1983 Oct 14.
Article in English | MEDLINE | ID: mdl-6643601

ABSTRACT

A method for the determination of isosorbide as a metabolite of isosorbide dinitrate at concentrations down to 200 ng/ml in human urine is described. After addition of a known amount of isomannide as internal standard to 50 microliter of urine, both compounds are extracted at basic pH into chloroform-isopropanol (4:1, v/v), which is then evaporated to dryness. They are then derivatized with heptafluorobutyric anhydride, and isosorbide is quantitated by capillary gas chromatography with electron-capture detection. A conjugate of isosorbide is determined in urine after enzymatic hydrolysis.


Subject(s)
Isosorbide Dinitrate/metabolism , Isosorbide/urine , Sorbitol/analogs & derivatives , Chromatography, Gas/methods , Humans , Hydrolysis , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...